LONDON–(BUSINESS WIRE)–#Biotechnology–The global epidermal growth factor receptor inhibitors market is
expected to post a CAGR of close to 9% during the period 2019-2023,
according to the latest market research report by Technavio.
The prevalence of various types of cancer has increased at a rapid pace
in recent years, resulting in a huge unmet need for drugs for the
treatment of these indications. This has created an opportunity for
vendors in the global oncology therapeutics market to conduct studies on
drugs such as EGFR inhibitors. Factors such as the increasing special
drug designation and the proven efficacy of EGFR inhibitors are leading
to quicker approval in the clinical stages. Therefore, the growing
prevalence of cancer indications is expected to fuel the EGFR inhibitors
market during the forecast period.
As per Technavio, new research areas will have a positive impact on the
market and contribute to its growth significantly over the forecast
period. This global
epidermal growth factor receptor inhibitors market 2019-2023 research
report also analyzes other important trends and market drivers that will
affect market growth over 2019-2023.
Global epidermal growth factor receptor
inhibitors market: New research areas
Various novel EGFR inhibitors have been approved recently due to their
proven efficacy for the treatment of different types of cancer. This has
also led various research institutes and pharmaceutical vendors to
expand their research areas. For instance, vendors are researching the
use of EGFR inhibitors for the treatment of inflammatory diseases and
monogenic diseases. The rising prevalence of various cancers and other
indications along with a huge unmet need have created immense growth
opportunities for vendors to research and develop novel EGFR inhibitors.
“Apart from the expansion of research areas, other factors such as
the increasing reimbursement programs, strong pipeline, and the
increasing awareness campaigns will have a significant impact on the
growth of the epidermal growth factor receptor inhibitors market size
during the forecast period,” says a senior analyst at Technavio.
Global epidermal growth factor receptor
inhibitors market: Segmentation analysis
This market research report segments the global epidermal growth factor
receptor inhibitors market by indication (lung cancer, colorectal
cancer, breast cancer, and others), and geographic regions (North
America, Europe, Asia, and ROW).
The North American region led the epidermal growth factor receptor
inhibitors market in 2018, followed by Europe, Asia, and ROW
respectively. The growth of the epidermal growth factor receptor
inhibitors market in North America can be attributed to factors such as
the increasing prevalence of the various type of major cancer
indications, heavy sales of approved therapeutics, and the presence of
various patient programs from both the vendors and the governments in
the region.
Looking for more information on this market? Request
a free sample report
Technavio’s sample reports are free of charge and contain multiple
sections of the report, such as the market size and forecast, drivers,
challenges, trends, and more.
Some of the key topics covered in the report include:
Market Landscape
- Market ecosystem
- Market characteristics
- Market segmentation analysis
Market Sizing
- Market definition
- Market size and forecast
Five Forces Analysis
Market Segmentation
Geographical Segmentation
- Regional comparison
- Key leading countries
Market Drivers
Market Challenges
Market Trends
Vendor Landscape
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
About Technavio
Technavio
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio’s comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team
at media@technavio.com.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US:
+1 844 364 1100
UK: +44 203 893 3200
www.technavio.com